Truist Financial’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $247K | Sell |
|
|||||
|
2025
Q1 | $257K | Sell |
|
|||||
|
2024
Q4 | $267K | Sell |
|
|||||
|
2024
Q3 | $265K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $162K | Sell |
|
|||||
|
2020
Q3 | $410K | Sell |
|
|||||
|
2020
Q2 | $654K | Buy |
|
|||||
|
2020
Q1 | $279K | Buy |
|
|||||
|
2019
Q4 | $389K | Buy |
|
|||||
|
2019
Q3 | $237K | Sell |
|
|||||
|
2019
Q2 | $282K | Sell |
|
|||||
|
2019
Q1 | $332K | Buy |
|
|||||
|
2018
Q4 | $289K | Sell |
|
|||||
|
2018
Q3 | $632K | Sell |
|
|||||
|
2018
Q2 | $494K | Sell |
|
|||||
|
2018
Q1 | $429K | Sell |
|
|||||
|
2017
Q4 | $359K | Sell |
|
|||||
|
2017
Q3 | $365K | Sell |
|
|||||
|
2017
Q2 | $327K | Sell |
|
|||||
|
2017
Q1 | $294K | Sell |
|
|||||
|
2016
Q4 | $311K | Sell |
|
|||||
|
2016
Q3 | $337K | Buy |
|
|||||
|
2016
Q2 | $301K | Buy |
|